DEISHER THERESA has a total of 14 patent applications. Its first patent ever was published in 2011. It filed its patents most often in Republic of Korea, EPO (European Patent Office) and Singapore. Its main competitors in its focus markets biotechnology and pharmaceuticals are CHEN LAN BO, NEXIMMUNE and UBI IP HOLDINGS.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 3 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Singapore | 2 | |
#4 | South Africa | 2 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | Dominican Republic | 1 | |
#8 | United States | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Deisher Theresa | 14 |
Publication | Filing date | Title |
---|---|---|
EP2605765A2 | Dexamethasone for use in treating osteoarthritis, liver failure, type-2 diabetes mellitus, stroke and parkinson's disease, in combination with stem cell treatment |